Systemic; Sclerosis, Progressive Completed Phase 2 Trials for Nilotinib (DB04868)

Also known as: Systemic Sclerosis (SSc) / Progressive Systemic Sclerosis / Sclerosis, Progressive Systemic / Sclerosis, Systemic / Systemic Sclerosis / Systemic scleroderma / Systemic sclerosis [scleroderma] / Scleroderma, Systemic / Systemic sclerosis (disorder) / Scleroderma syndrome / Systemic sclerosis, unspecified / Scleroderma (& [systemic sclerosis]) / Scleroderma (& [acrosclerosis] or [systemic sclerosis])

IndicationStatusPhase
DBCOND0138440 (Systemic; Sclerosis, Progressive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01166139Nilotinib in the Treatment of Systemic SclerosisTreatment